Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sorcin pseudogene 2 (SRIP2) is a processed pseudogene located on the X chromosome at region Xq21.31, spanning base pairs 89,367,435 to 89,367,600[3]. It is a non-functional genomic remnant related to the functional sorcin gene (SRI), but does not encode a protein and is not known to be transcribed or have a current biological or clinical role. No therapeutic roles, drug interactions, disease associations, or biomarker utility are reported in the literature[3]. Key point: Sorcin pseudogene 2 (SRIP2) is not a protein, enzyme, receptor, or therapeutic target—unlike the functional Sorcin (SRI) gene, which plays a well-documented role in calcium homeostasis, cancer, and multidrug resistance[1][2][4][5]. The two entities should not be confused.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sorcin pseudogene 2 (SRIP2).